hivandhepatitis.com - HIV-Related ConditionsUp-to-date information about approved and experimental therapies for HIV/AIDS, Hepatitis, and related conditions.http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-related-conditions
Fri, 09 Dec 2016 15:25:24 +0000Joomla! 1.6 - Open Source Content Managementen-gbHIV-Positive People May Lose More Years of Life from Smoking than from HIV/AIDShttp://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-related-conditions/5916-hiv-positive-people-lose-more-years-of-life-from-smoking-than-from-hivaids
http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-related-conditions/5916-hiv-positive-people-lose-more-years-of-life-from-smoking-than-from-hivaids
People with HIV on effective antiretroviral treatment who smoke cigarettes may incur more risk of death and reduction in life expectancy from smoking than from HIV/AIDS-related conditions, according to a study described in the November 3 advance edition of the Journal of Infectious Diseases.

]]>liz@black-rose.com (Liz Highleyman)Mon, 07 Nov 2016 08:00:00 +0000IDWeek 2016: Only a Small Proportion of HIV+ Gay Men Receive Anal Cancer Screeninghttp://www.hivandhepatitis.com/hiv-related-conditions/hiv-cancer/5897-idweek-2016-only-a-small-proportion-of-gay-men-receive-anal-cancer-screening
http://www.hivandhepatitis.com/hiv-related-conditions/hiv-cancer/5897-idweek-2016-only-a-small-proportion-of-gay-men-receive-anal-cancer-screening
In the absence of national screening guidelines, only 11% of HIV-positive gay and bisexual men in the U.S. received anal Pap smears to detect anal cancer or precancerous cell changes during 2009-2012, with disparities between patient groups and variations across centers, according to a presentation at IDWeek, taking place this week in New Orleans.

]]>liz@black-rose.com (Liz Highleyman)Fri, 28 Oct 2016 07:00:00 +0000HIV Glasgow: French Study Reveals Growing Complexity of Medical Needs as People with HIV Agehttp://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-related-conditions/5898-hiv-glasgow-french-study-reveals-growing-complexity-of-medical-needs-as-people-with-hiv-age
http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-related-conditions/5898-hiv-glasgow-french-study-reveals-growing-complexity-of-medical-needs-as-people-with-hiv-age
The complexity of the needs of people living with HIV will continue to increase as the population ages, and clinicians need to go beyond thinking about co-morbidities to consider multi-morbidities -- clusters of medical conditions that complicate one another -- when caring for these people, Edouard Battegay from the University Hospital Zurich told attendees at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow) this week.

]]>liz@black-rose.com (Keith Alcorn)Fri, 28 Oct 2016 07:00:00 +0000AIDS 2016: Managing Non-Communicable Diseases Among People Living with HIVhttp://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-related-conditions/5839-aids-2016-managing-non-communicable-diseases-among-people-living-with-hiv
http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-related-conditions/5839-aids-2016-managing-non-communicable-diseases-among-people-living-with-hiv
Speakers at the recent 21st International AIDS Conference in Durban addressed non-communicable diseases (NCDs) -- including cardiovascular diseases, diabetes, cancers, and other illnesses -- which have become more common complications for people with HIV who are living longer on antiretroviral therapy (ART). NCDs represent a significant challenge in low- and middle-income countries, where the burden of these illnesses has been reaching epidemic proportions, but where health systems have traditionally focused on providing episodic rather than chronic care.

]]>liz@black-rose.com (HIVandHepatitis.com)Thu, 28 Jul 2016 07:00:00 +0000Mild Neurological Impairment Is Common During Early HIV Infectionhttp://www.hivandhepatitis.com/hiv-related-conditions/hiv-neurocognitive/5774-asm-microbe-2016-switching-from-tenofovir-df-to-taf-improves-bone-and-kidney-safety
http://www.hivandhepatitis.com/hiv-related-conditions/hiv-neurocognitive/5774-asm-microbe-2016-switching-from-tenofovir-df-to-taf-improves-bone-and-kidney-safety
People with HIV infection often have neurological signs and symptoms very soon after becoming infected -- even before they develop antibodies that show up on a test -- but these are typically mild to moderate and resolve after starting effective antiretroviral therapy (ART), according to a study published in the June 10 advance online edition of Neurology. These findings provide further evidence for starting treatment as soon as possible after HIV diagnosis.

]]>liz@black-rose.com (UCSF)Sun, 10 Jul 2016 07:00:00 +0000CROI 2016: Antidepressant Improves HIV-Related Cognitive Impairmenthttp://www.hivandhepatitis.com/hiv-related-conditions/hiv-neurocognitive/5655-croi-2016-antidepressant-improves-function-in-people-with-hiv-related-cognitive-impairment
http://www.hivandhepatitis.com/hiv-related-conditions/hiv-neurocognitive/5655-croi-2016-antidepressant-improves-function-in-people-with-hiv-related-cognitive-impairment
The SSRI antidepressant paroxetine (Paxil) was associated with a modest improvement in cognitive function and reduced central nervous system inflammation among people with HIV-related neurocognitive disorder, but the antifungal drug fluconazole showed no apparent benefit even though it reduced oxidative stress, according to a study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) last month in Boston.

]]>liz@black-rose.com (Liz Highleyman)Thu, 24 Mar 2016 07:00:00 +0000CROI 2016: Women and African Americans with HIV Have a Higher Risk of Strokehttp://www.hivandhepatitis.com/hiv-related-conditions/hiv-cardiovascular/5652-croi-2016-women-and-african-americans-with-hiv-have-a-higher-risk-of-stroke
http://www.hivandhepatitis.com/hiv-related-conditions/hiv-cardiovascular/5652-croi-2016-women-and-african-americans-with-hiv-have-a-higher-risk-of-stroke
The risk of stroke among people living with HIV is highest among people with unsuppressed viral load, and among women and African Americans, according to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016)last month in Boston.

]]>liz@black-rose.com (Keith Alcorn & Michael Carter)Wed, 23 Mar 2016 07:00:00 +0000CROI 2016: HIV-Related Factors Increase Risk of Strokehttp://www.hivandhepatitis.com/hiv-related-conditions/hiv-cardiovascular/5642-croi-2016-hiv-related-factors-increase-risk-of-stroke
http://www.hivandhepatitis.com/hiv-related-conditions/hiv-cardiovascular/5642-croi-2016-hiv-related-factors-increase-risk-of-stroke
HIV-related risk factors seem to increase the risk of stroke -- the sudden death of brain cells due to a rupture or obstruction of blood vessels in the brain -- according to ongoing research in a growing number of large epidemiological cohort studies. Recent data from 5 of these were presented during the first-ever poster discussion session on stroke at the Conference on Retroviruses and Opportunistic Infections (CROI), which took place last month in Boston.

]]>liz@black-rose.com (Theo Smart)Tue, 08 Mar 2016 08:00:00 +0000CROI 2016: Early Antiretroviral Therapy Has No Impact on Cardiovascular Disease Markerhttp://www.hivandhepatitis.com/hiv-related-conditions/hiv-cardiovascular/5632-croi-2016-early-antiretroviral-therapy-has-no-impact-on-cardiovascular-disease-marker
http://www.hivandhepatitis.com/hiv-related-conditions/hiv-cardiovascular/5632-croi-2016-early-antiretroviral-therapy-has-no-impact-on-cardiovascular-disease-marker
Starting treatment at a CD4 cell count above 500 cells/mm3 does not lead to improvement in an important early warning sign of cardiovascular disease, and investigators are still unsure whether people who start treatment at high CD4 counts will have the same increased risk of cardiovascular disease as that reported in people with HIV over the past 15 years, according to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston last week.

]]>liz@black-rose.com (Keith Alcorn)Fri, 04 Mar 2016 08:00:00 +0000CROI 2016: Study Does Not Support Routine HPV Vaccination to Prevent Anal Cancer in People with HIVhttp://www.hivandhepatitis.com/hiv-related-conditions/hiv-cancer/5625-croi-2016-study-does-not-support-routine-hpv-vaccination-to-prevent-anal-cancer-in-people-with-hiv
http://www.hivandhepatitis.com/hiv-related-conditions/hiv-cancer/5625-croi-2016-study-does-not-support-routine-hpv-vaccination-to-prevent-anal-cancer-in-people-with-hiv
The quadrivalent HPV vaccine Gardasil does not protect older adults with HIV against persistent anal infection with human papillomavirus or the development of high-grade anal lesions (HSIL), but the ACTG A5298 study showed some evidence that it may protect against persistent oral HPV infection, Timothy Wilkin of Weill Cornell Medical College reported at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) last week in Boston.

]]>liz@black-rose.com (Keith Alcorn)Tue, 01 Mar 2016 08:00:00 +0000CROI 2016: Early Antiretroviral Therapy Reduces the Risk of Infection-Related Cancershttp://www.hivandhepatitis.com/hiv-related-conditions/hiv-cancer/5613-croi-2016-early-antiretroviral-therapy-reduces-the-risk-of-infection-related-cancers
http://www.hivandhepatitis.com/hiv-related-conditions/hiv-cancer/5613-croi-2016-early-antiretroviral-therapy-reduces-the-risk-of-infection-related-cancers
People who started antiretroviral therapy at a CD4 cell count above 500 had a significantly lower risk of developing a cancer with an infectious cause when compared to people who started treatment at a CD4 count of 350 or below, an analysis of the START study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston has shown.

]]>liz@black-rose.com (HIVandHepatitis.com)Fri, 26 Feb 2016 08:00:00 +0000CROI 2016: HIV in the Brain -- New Tools and Treatment Options to Keep Your Mind Beautifulhttp://www.hivandhepatitis.com/hiv-related-conditions/hiv-neurocognitive/5609-croi-2016-hiv-in-the-brain-new-tools-and-treatment-options-to-keep-your-mind-beautiful
http://www.hivandhepatitis.com/hiv-related-conditions/hiv-neurocognitive/5609-croi-2016-hiv-in-the-brain-new-tools-and-treatment-options-to-keep-your-mind-beautiful
In the future, HIV-related neurocognitive disorder (HAND) may become less common because of the earlier use of antiretroviral therapy (ART), but neurological disease -- caused by a number of different factors -- will remain an important issue as people with HIV live longer, according to several presentations in a symposium called "A beautiful Mind, Keeping It," held at the annual Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston.